UK national survey of enucleation, evisceration and orbital implant trends.
OBJECTIVE
To evaluate current clinical practice in the UK in the management of the anophthalmic socket; choice of enucleation, evisceration, type of orbital implant, wrap, motility pegging and complications.


METHODS
All consultant ophthalmologists in the UK were surveyed by postal questionnaire. Questions included their practice subspecialty and number of enucleations and eviscerations performed in 2003. Specific questions addressed choice of implant, wrap, motility pegging and complications.


RESULTS
456/896 (51%) consultants responded, of which 162 (35%) had a specific interest in oculoplastics, lacrimal, orbits or oncology. Only 243/456 (53%) did enucleations or eviscerations. 92% inserted an orbital implant after primary enucleation, 69% after non-endophthalmitis evisceration, whereas only 43% did so after evisceration for endophthalmitis (50% as a delayed procedure). 55% used porous orbital implants (porous polyethylene, hydroxyapatite or alumina) as their first choice and 42% used acrylic. Most implants inserted were spherical, sized 18-20 mm in diameter. 57% wrapped the implant after enucleation, using salvaged autogenous sclera (20%), donor sclera (28%) and synthetic Vicryl or Mersilene mesh (42%). A minority (7%) placed motility pegs in selected cases, usually as a secondary procedure. 14% of respondents reported implant exposure for each type of procedure and extrusion was reported by 4% after enucleation and 3% after evisceration.


CONCLUSIONS
This survey highlights contemporary anophthalmic socket practice in the UK. Most surgeons use porous orbital implants with a synthetic wrap after enucleation and only few perform motility pegging.
Viswanathan
P
P
Department of Ophthalmology, Watford General Hospital, Watford, UK.
Sagoo
Mandeep S
MS
Olver
Jane M
JM
D003253:Consultants; D015353:Eye Enucleation / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data*; D017234:Eye Evisceration / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data*; D006801:Humans; D007430:Intraoperative Care / Q000379:methods; D009885:Ophthalmology / Q000706:statistics & numerical data*; D020273:Orbital Implants / Q000009:adverse effects / Q000706:statistics & numerical data*; D011364:Professional Practice / Q000706:statistics & numerical data*; D006113:United Kingdom